India · Delayed Price · Currency is INR Avience Biomedicals Statistics
Total Valuation
NSE:AVIENCE has a market cap or net worth of INR 1.37 billion. The enterprise value is 1.63 billion.
| Market Cap | 1.37B |
| Enterprise Value | 1.63B |
Important Dates
The next estimated earnings date is Tuesday, February 9, 2027.
| Earnings Date | Feb 9, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:AVIENCE has 5.49 million shares outstanding. The number of shares has increased by 199.66% in one year.
| Current Share Class | 5.49M |
| Shares Outstanding | 5.49M |
| Shares Change (YoY) | +199.66% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 66.71% |
| Owned by Institutions (%) | n/a |
| Float | 1.57M |
Valuation Ratios
The trailing PE ratio is 12.19.
| PE Ratio | 12.19 |
| Forward PE | n/a |
| PS Ratio | 2.39 |
| PB Ratio | 2.22 |
| P/TBV Ratio | 2.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 23.21 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 16.73 |
| EV / Sales | 2.85 |
| EV / EBITDA | 9.70 |
| EV / EBIT | 10.70 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.02, with a Debt / Equity ratio of 0.44.
| Current Ratio | 2.02 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | 1.62 |
| Debt / FCF | n/a |
| Interest Coverage | 10.99 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 20.04% |
| Return on Capital Employed (ROCE) | 20.65% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:AVIENCE has paid 41.19 million in taxes.
| Income Tax | 41.19M |
| Effective Tax Rate | 29.70% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 292.08 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 42.48 |
| Average Volume (20 Days) | 17,190 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AVIENCE had revenue of INR 572.87 million and earned 97.51 million in profits. Earnings per share was 20.50.
| Revenue | 572.87M |
| Gross Profit | 260.05M |
| Operating Income | 152.42M |
| Pretax Income | 138.71M |
| Net Income | 97.51M |
| EBITDA | 168.06M |
| EBIT | 152.42M |
| Earnings Per Share (EPS) | 20.50 |
Balance Sheet
The company has 57.29 million in cash and 271.51 million in debt, with a net cash position of -214.21 million or -39.05 per share.
| Cash & Cash Equivalents | 57.29M |
| Total Debt | 271.51M |
| Net Cash | -214.21M |
| Net Cash Per Share | -39.05 |
| Equity (Book Value) | 616.68M |
| Book Value Per Share | 112.50 |
| Working Capital | 294.89M |
Cash Flow
In the last 12 months, operating cash flow was 59.06 million and capital expenditures -134.49 million, giving a free cash flow of -75.42 million.
| Operating Cash Flow | 59.06M |
| Capital Expenditures | -134.49M |
| Depreciation & Amortization | 12.04M |
| Net Borrowing | 67.77M |
| Free Cash Flow | -75.42M |
| FCF Per Share | -13.75 |
Margins
Gross margin is 45.39%, with operating and profit margins of 26.61% and 17.02%.
| Gross Margin | 45.39% |
| Operating Margin | 26.61% |
| Pretax Margin | 24.21% |
| Profit Margin | 17.02% |
| EBITDA Margin | 29.34% |
| EBIT Margin | 26.61% |
| FCF Margin | n/a |
Dividends & Yields
NSE:AVIENCE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -199.66% |
| Shareholder Yield | -199.66% |
| Earnings Yield | 8.20% |
| FCF Yield | -5.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |